The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

Strides Pharma Science share price has rallied 19% in one month and 25% in three months. The small-cap stock is up 10% YTD ...

Despite some recent reversals in trade policy, the broader trend still indicates a rise in trade barriers compared to the ...

Indian Hotels Company, Mazagon Dock Shipbuilders, Max Healthcare Institute, Solar Industries India, Shree Cements, Mankind ...

Shares Biotechnology ETF offers efficient, diversified exposure to the sector's revival, balancing risk and cost for ...

Western drugmakers, investors increasingly aim to acquire Chinese compounds.

Lilly dominates GLP-1 market but faces near-term headwinds, while AstraZeneca boasts steady growth, rising estimates and a higher dividend yield.

Smart packaging with QR codes, RFID, and tamper-evident seals drives USA pharma secondary packaging demand, ensuring safety, ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...

Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...